FDA.reportPublic FDA data

Application 040733

Type
ANDA
Sponsor
MURTY PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DIPYRIDAMOLEDIPYRIDAMOLETABLET;ORAL25MGNoNo
002DIPYRIDAMOLEDIPYRIDAMOLETABLET;ORAL50MGNoNo
003DIPYRIDAMOLEDIPYRIDAMOLETABLET;ORAL75MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
64980-133DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-133DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-133DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-133DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-133DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-134DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-134DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-134DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-134DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-134DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-135DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-135DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-135DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-135DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
64980-135DIPYRIDAMOLEDIPYRIDAMOLERising Pharmaceuticals, Inc.ANDACurrent
71205-894DIPYRIDAMOLEDIPYRIDAMOLEProficient Rx LPANDACurrent
71205-894DIPYRIDAMOLEDIPYRIDAMOLEProficient Rx LPANDACurrent
71205-895DIPYRIDAMOLEDIPYRIDAMOLEProficient Rx LPANDACurrent
71205-895DIPYRIDAMOLEDIPYRIDAMOLEProficient Rx LPANDACurrent
71205-896DIPYRIDAMOLEDIPYRIDAMOLEProficient Rx LPANDACurrent
71205-896DIPYRIDAMOLEDIPYRIDAMOLEProficient Rx LPANDACurrent